Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Insulin Pen Needle Market by Type (Standard Insulin Pen Needles, Safety Insulin Pen Needles), By Application (Home Use, Medical Institutions, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Insulin Pen Needle Market by Type (Standard Insulin Pen Needles, Safety Insulin Pen Needles), By Application (Home Use, Medical Institutions, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 196947 3300 Pharma & Healthcare 377 233 Pages 4.9 (31)
                                          

The global insulin pen needle market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing prevalence of diabetes and rising awareness about diabetes management. Insulin pen needles are used for injecting insulin in diabetic patients, which helps in controlling blood sugar levels. Insulin pen needles are available in two types: standard and safety needles. Standard insulin pen needles are disposable and have a shorter needle length than safety ones, which makes them more prone to injury or infection when compared with safety ones. Safety insulin pens have longer needle lengths that make it difficult for the user to accidentally inject themselves with the needle or injure someone else with it while handling it carelessly. Insulin Pen Needles Market By Type (Standard Insulin Pen Needles, Safety Insulin Pen Needles), By Application (Home Use, Medical Institutions) And By Region (North America, Latin America, Europe, Asia Pacific And Middle East & Africa) Forecast From 2021 To 2030.

Some Of The Growth Factors Of This Market:

  1. The increasing prevalence of diabetes is a major factor driving the growth of the insulin pen needle market.
  2. The increasing number of people suffering from diabetes is a major factor driving the growth of the insulin pen needle market.
  3. The rising awareness about diabetes and its complications is a major factor driving the growth of the insulin pen needle market.
  4. Increasing disposable income in emerging economies such as China and India will drive demand for healthcare products, including insulin pens and needles.
  5. Increasing incidence rates for type 2 diabetes are also expected to fuel demand for insulin pens and needles.

Industry Growth Insights published a new data on “Insulin Pen Needle Market”. The research report is titled “Insulin Pen Needle Market research by Types (Standard Insulin Pen Needles, Safety Insulin Pen Needles), By Applications (Home Use, Medical Institutions, Others), By Players/Companies BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed, Owen Mumford, HTL-Strefa, Beipu, Kangdelai, Ulticare, Allison Medical, Dongbao”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Insulin Pen Needle Market Research Report

By Type

Standard Insulin Pen Needles, Safety Insulin Pen Needles

By Application

Home Use, Medical Institutions, Others

By Companies

BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed, Owen Mumford, HTL-Strefa, Beipu, Kangdelai, Ulticare, Allison Medical, Dongbao

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

233

Number of Tables & Figures

164

Customization Available

Yes, the report can be customized as per your need.


Global Insulin Pen Needle Industry Outlook


Global Insulin Pen Needle Market Report Segments:

The global Insulin Pen Needle market is segmented on the basis of:

Types

Standard Insulin Pen Needles, Safety Insulin Pen Needles

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Home Use, Medical Institutions, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. BD
  2. Novo Nordisk
  3. Artsana
  4. B. Braun
  5. Terumo
  6. Ypsomed
  7. Owen Mumford
  8. HTL-Strefa
  9. Beipu
  10. Kangdelai
  11. Ulticare
  12. Allison Medical
  13. Dongbao

Global Insulin Pen Needle Market Overview


Highlights of The Insulin Pen Needle Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Standard Insulin Pen Needles
    2. Safety Insulin Pen Needles
  1. By Application:

    1. Home Use
    2. Medical Institutions
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Insulin Pen Needle Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Insulin Pen Needle Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Insulin pen needles are a type of insulin delivery device that is used to inject insulin into the body. They come in various sizes and shapes, and can be fitted with different types of tips. Insulin pen needles are typically more comfortable to use than other forms of insulin delivery, such as injections or pens.

Some of the key players operating in the insulin pen needle market are BD, Novo Nordisk, Artsana, B. Braun, Terumo, Ypsomed, Owen Mumford, HTL-Strefa, Beipu, Kangdelai, Ulticare, Allison Medical, Dongbao.

The insulin pen needle market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Insulin Pen Needle Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Insulin Pen Needle Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Insulin Pen Needle Market - Supply Chain
   4.5. Global Insulin Pen Needle Market Forecast
      4.5.1. Insulin Pen Needle Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Insulin Pen Needle Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Insulin Pen Needle Market Absolute $ Opportunity

5. Global Insulin Pen Needle Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Insulin Pen Needle Market Size and Volume Forecast by Type
      5.3.1. Standard Insulin Pen Needles
      5.3.2. Safety Insulin Pen Needles
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Insulin Pen Needle Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Insulin Pen Needle Market Size and Volume Forecast by Application
      6.3.1. Home Use
      6.3.2. Medical Institutions
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Insulin Pen Needle Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Insulin Pen Needle Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Insulin Pen Needle Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Insulin Pen Needle Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Insulin Pen Needle Demand Share Forecast, 2019-2026

9. North America Insulin Pen Needle Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Insulin Pen Needle Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Insulin Pen Needle Market Size and Volume Forecast by Application
      9.4.1. Home Use
      9.4.2. Medical Institutions
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Insulin Pen Needle Market Size and Volume Forecast by Type
      9.7.1. Standard Insulin Pen Needles
      9.7.2. Safety Insulin Pen Needles
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Insulin Pen Needle Demand Share Forecast, 2019-2026

10. Latin America Insulin Pen Needle Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Insulin Pen Needle Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Insulin Pen Needle Market Size and Volume Forecast by Application
      10.4.1. Home Use
      10.4.2. Medical Institutions
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Insulin Pen Needle Market Size and Volume Forecast by Type
      10.7.1. Standard Insulin Pen Needles
      10.7.2. Safety Insulin Pen Needles
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Insulin Pen Needle Demand Share Forecast, 2019-2026

11. Europe Insulin Pen Needle Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Insulin Pen Needle Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Insulin Pen Needle Market Size and Volume Forecast by Application
      11.4.1. Home Use
      11.4.2. Medical Institutions
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Insulin Pen Needle Market Size and Volume Forecast by Type
      11.7.1. Standard Insulin Pen Needles
      11.7.2. Safety Insulin Pen Needles
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Insulin Pen Needle Demand Share, 2019-2026

12. Asia Pacific Insulin Pen Needle Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Insulin Pen Needle Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Insulin Pen Needle Market Size and Volume Forecast by Application
      12.4.1. Home Use
      12.4.2. Medical Institutions
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Insulin Pen Needle Market Size and Volume Forecast by Type
      12.7.1. Standard Insulin Pen Needles
      12.7.2. Safety Insulin Pen Needles
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Insulin Pen Needle Demand Share, 2019-2026

13. Middle East & Africa Insulin Pen Needle Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Insulin Pen Needle Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Insulin Pen Needle Market Size and Volume Forecast by Application
      13.4.1. Home Use
      13.4.2. Medical Institutions
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Insulin Pen Needle Market Size and Volume Forecast by Type
      13.7.1. Standard Insulin Pen Needles
      13.7.2. Safety Insulin Pen Needles
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Insulin Pen Needle Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Insulin Pen Needle Market: Market Share Analysis
   14.2. Insulin Pen Needle Distributors and Customers
   14.3. Insulin Pen Needle Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. BD
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Novo Nordisk
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Artsana
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. B. Braun
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Terumo
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Ypsomed
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Owen Mumford
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. HTL-Strefa
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. Beipu
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Kangdelai
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Ulticare
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. Allison Medical
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Dongbao
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us